Literature DB >> 28778446

Family-based association analysis of NAV2 gene with the risk and age at onset of Alzheimer's disease.

Ke-Sheng Wang1, Ying Liu2, Chun Xu3, Xuefeng Liu4, Xingguang Luo5.   

Abstract

The neuron navigator 2 (NAV2) gene is highly expressed in brain and involved in the nervous system development and may play a role in Alzheimer's disease (AD). We aimed to investigate the associations of 317 single-nucleotide polymorphisms (SNPs) in the NAV2 gene with the risk and age at onset (AAO) of AD using a family-based sample (1266 AD cases and 1279 healthy relatives). Association with the risk of AD was assessed using family-based association test -generalized estimating equations (FBAT- GEE) statistics while the association with AAO as a quantitative trait was evaluated using the FBAT-Wilcoxon statistic. Single marker analysis showed that 20 SNPs were significantly associated with the risk of AD (top SNP rs7112354 with p=8.46×10-4) and 11 SNPs were associated with AAO (top SNP rs1354269 with p=2.87×10-3). Interestingly, two SNPs rs17614100 and rs12364788 were associated with both the risk (p=1.7×10-2 and 2.71×10-2; respectively) and AAO (p=1.85×10-3 and 6.06×10-3; respectively). Haplotype analyses further supported the results of single marker analyses. In addition, functional analysis showed that NAV2 mRNA had significant expression across ten human brain regions examined and significantly correlated with APOE expression in four of ten regions. The present study is the first study providing evidence of several genetic variants within the NAV2 gene influencing the risk and AAO of AD.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age at onset; Alzheimer's disease; Family-based design; NAV2; Polymorphisms; mRNA

Mesh:

Substances:

Year:  2017        PMID: 28778446      PMCID: PMC6167010          DOI: 10.1016/j.jneuroim.2017.06.010

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  24 in total

1.  Family-based association tests for survival and times-to-onset analysis.

Authors:  Christoph Lange; Deborah Blacker; Nan M Laird
Journal:  Stat Med       Date:  2004-01-30       Impact factor: 2.373

2.  A mammalian homolog of unc-53 is regulated by all-trans retinoic acid in neuroblastoma cells and embryos.

Authors:  R A Merrill; L A Plum; M E Kaiser; M Clagett-Dame
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

3.  Age at onset in two common neurodegenerative diseases is genetically controlled.

Authors:  Yi-Ju Li; William K Scott; Dale J Hedges; Fengyu Zhang; P Craig Gaskell; Martha A Nance; Ray L Watts; Jean P Hubble; William C Koller; Rajesh Pahwa; Matthew B Stern; Bradley C Hiner; Joseph Jankovic; Fred A Allen; Christopher G Goetz; Frank Mastaglia; Jeffrey M Stajich; Rachel A Gibson; Lefkos T Middleton; Ann M Saunders; Burton L Scott; Gary W Small; Kristin K Nicodemus; Allison D Reed; Donald E Schmechel; Kathleen A Welsh-Bohmer; P Michael Conneally; Allen D Roses; John R Gilbert; Jeffery M Vance; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

4.  Neuron navigator: a human gene family with homology to unc-53, a cell guidance gene from Caenorhabditis elegans.

Authors:  Tamara Maes; Anna Barceló; Carlos Buesa
Journal:  Genomics       Date:  2002-07       Impact factor: 5.736

5.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

6.  Role of genes and environments for explaining Alzheimer disease.

Authors:  Margaret Gatz; Chandra A Reynolds; Laura Fratiglioni; Boo Johansson; James A Mortimer; Stig Berg; Amy Fiske; Nancy L Pedersen
Journal:  Arch Gen Psychiatry       Date:  2006-02

7.  The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort.

Authors:  Joseph H Lee; Rong Cheng; Nicole Schupf; Jennifer Manly; Rafael Lantigua; Yaakov Stern; Ekaterina Rogaeva; Yosuke Wakutani; Lindsay Farrer; Peter St George-Hyslop; Richard Mayeux
Journal:  Arch Neurol       Date:  2007-04

8.  Isolation of HELAD1, a novel human helicase gene up-regulated in colorectal carcinomas.

Authors:  Hideyuki Ishiguro; Takashi Shimokawa; Tatsuhiko Tsunoda; Toshihiro Tanaka; Yoshitaka Fujii; Yusuke Nakamura; Yoichi Furukawa
Journal:  Oncogene       Date:  2002-09-12       Impact factor: 9.867

9.  Hippocampal transcriptome-guided genetic analysis of correlated episodic memory phenotypes in Alzheimer's disease.

Authors:  Jingwen Yan; Sungeun Kim; Kwangsik Nho; Rui Chen; Shannon L Risacher; Jason H Moore; Andrew J Saykin; Li Shen
Journal:  Front Genet       Date:  2015-03-26       Impact factor: 4.599

10.  Neuron navigator 2 overexpression indicates poor prognosis of colorectal cancer and promotes invasion through the SSH1L/cofilin-1 pathway.

Authors:  Fengbo Tan; Hong Zhu; Yiming Tao; Nanhui Yu; Qian Pei; Heli Liu; Yuan Zhou; Haifan Xu; Xiangping Song; Yuqiang Li; Zhongyi Zhou; Xiao He; Xingwen Zhang; Haiping Pei
Journal:  J Exp Clin Cancer Res       Date:  2015-10-09
View more
  2 in total

1.  Genetic associations with age of menopause in familial longevity.

Authors:  Harold Bae; Kathryn L Lunetta; Joanne M Murabito; Stacy L Andersen; Nicole Schupf; Thomas Perls; Paola Sebastiani
Journal:  Menopause       Date:  2019-10       Impact factor: 2.953

2.  Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes.

Authors:  Ana Macedo; Carlos Gómez; Miguel Ângelo Rebelo; Jesús Poza; Iva Gomes; Sandra Martins; Aarón Maturana-Candelas; Víctor Gutiérrez-de Pablo; Luis Durães; Patrícia Sousa; Manuel Figueruelo; María Rodríguez; Carmen Pita; Miguel Arenas; Luis Álvarez; Roberto Hornero; Alexandra M Lopes; Nádia Pinto
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.